NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 914 filers reported holding NOVARTIS A G in Q4 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,583,000 | +5587.3% | 39,235 | +4441.1% | 0.26% | +4250.0% |
| Q4 2016 | $63,000 | -43.2% | 864 | -38.7% | 0.01% | -45.5% |
| Q3 2016 | $111,000 | -4.3% | 1,410 | 0.0% | 0.01% | -8.3% |
| Q2 2016 | $116,000 | +13.7% | 1,410 | 0.0% | 0.01% | +20.0% |
| Q1 2016 | $102,000 | -15.7% | 1,410 | 0.0% | 0.01% | -9.1% |
| Q4 2015 | $121,000 | -6.9% | 1,410 | 0.0% | 0.01% | -8.3% |
| Q3 2015 | $130,000 | -6.5% | 1,410 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $139,000 | 0.0% | 1,410 | 0.0% | 0.01% | +9.1% |
| Q1 2015 | $139,000 | -99.3% | 1,410 | -99.4% | 0.01% | -99.4% |
| Q4 2014 | $21,312,000 | – | 230,000 | – | 1.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |